US routes HIV funding straight to health ministries, tied to a 2030 handover

A cluster of notices published in the Federal Register in the second half of August 2026 offers a concrete look at how the US government is reshaping its global HIV money: not through the network of outside contractors that defined the programme's first two decades, but through direct awards to the health ministries of the countries doing the work.

What the notices say

On 17 August, the Centers for Disease Control and Prevention announced the award of approximately $30,000,000 in Federal Fiscal Year 2026 funding to the Ministry of Health of Ethiopia, to help build and oversee national HIV and tuberculosis programmes through the ministry and its affiliates [s1]. The same day, CDC announced approximately $15,000,000 for the Public Health Center of the Ministry of Health of Ukraine, to advance HIV and TB epidemic control [s3]. Two days later, on 19 August, it announced approximately $15,000,000 for the Ministry of Health of Zambia, to lead and oversee the national HIV response [s2].

Each is structured as a sole-source cooperative agreement — an award made to a single named recipient rather than competed — and each states that funding amounts for years two through five will be set at continuation, subject to the availability of funds [s1] [s2] [s3]. The common thread is the recipient: in every case the money goes to the government health authority itself.

The 2030 logic

The clearest statement of intent is in the Zambia notice, which frames the award as supporting the country, through its Ministry of Health, to lead and oversee the national HIV response "in alignment with the U.S. Government's (USG) goal to transition to the host government by 2030" [s2]. That single phrase captures the strategy the three awards share: a planned handover of ownership of the HIV response from US-funded intermediaries to national governments by the end of the decade.

The Ethiopia and Ukraine awards point the same direction in their design if not their wording. The Ethiopian agreement is explicitly about building and overseeing national HIV and TB programmes through the ministry [s1]. The Ukrainian one lists activities — enhancing integrated HIV service delivery, improving antiretroviral therapy initiation and retention, and strengthening the national laboratory system to respond to emerging pathogens — that describe a national system being reinforced rather than a parallel one being run alongside it [s3].

Why the recipient matters

For most of its history, US global HIV funding has flowed heavily through international non-governmental organisations, universities and private contractors that deliver services on the ground. Channelling money instead to a finance or health ministry changes who holds the budget, who is accountable for results, and who is expected to keep the programme running when external funding tapers. It is the mechanism through which a "transition to the host government" actually happens: the government has to be the one receiving and managing the funds well before it is the one paying for them.

The trade-offs are real and cut both ways. Direct government financing can strengthen national systems, reduce duplicative overheads and build the institutional capacity that outlasts any single donor. It also concentrates responsibility — and risk — in ministries whose own capacity varies, and in Ukraine's case, a health system operating under wartime conditions [s3]. The notices themselves make no claims about outcomes; they are awards, not evaluations.

What the numbers are, and are not

The dollar figures are worth reading precisely. These are single-year FFY2026 amounts — approximately $30 million for Ethiopia and approximately $15 million each for Zambia and Ukraine — with later years left at continuation rather than fixed [s1] [s2] [s3]. They are not the total US HIV investment in any of these countries, which flows through multiple channels, and the notices give no comparison to prior years. What they do document is the routing: money moving directly into national health authorities under a stated plan to make those authorities the owners of the response.

What to watch

The test of a handover strategy is what happens as the external share shrinks. The awards set 2030 as the horizon for Zambia's transition [s2]; whether the ministries can absorb the funds, sustain antiretroviral therapy coverage and hold the gains as continuation-year amounts are decided will be visible in the epidemic data long before the transition date arrives. For now, the Federal Register entries mark a direction of travel: US HIV funding is being pointed at governments, on a clock.

Sources

• Notice of Award of a Sole Source Cooperative Agreement To Fund the Ministry of Health of Ethiopia, Centers for Disease Control and Prevention (Federal Register), 17 August 2026
• Notice of Award of a Sole Source Cooperative Agreement To Fund Ministry of Health Zambia, Centers for Disease Control and Prevention (Federal Register), 19 August 2026
• Notice of Award of a Sole Source Cooperative Agreement To Fund Public Health Center of the Ministry of Health of Ukraine, Centers for Disease Control and Prevention (Federal Register), 17 August 2026